Private Investment Opportunities for Medical Professionals

You Spend Your Career Building Trust. Now Meet the Company Building the Infrastructure Behind It.

iQUBE is developing a trust-infrastructure company for a world that increasingly needs to prove who, and what, is real. IPO EQUITIES is the private invitation channel through which you can explore it.

Your Private Invitation Starts Here.

Request the company information. Decide in your own time.

No obligation to invest. Receive the information and decide whether the opportunity is right for you.

Capital at risk. Private, illiquid, pre-IPO shares. No listing, return or exit is guaranteed.

Before Anyone Trusts You With Their Health, They Want to Know Who You Are.

Your career rests on verified proof. Qualifications that were examined and awarded. A medical registration that can be checked. An identity confirmed, a reputation earned patient by patient, year by year. Trust, in your profession, is not assumed — it is evidenced.

Now step back and look at the wider world. Businesses must prove they are genuine. Owners must prove they are who they claim. Credentials must be checked, re-checked, and checked again across every organisation that touches them — often from scratch, every single time. The same problem you've mastered in medicine runs through the entire economy.

Trust matters everywhere. iQUBE is developing the infrastructure to help prove it.

The Concept

Not Just Another App. Infrastructure for a World That Needs Proof.

iQUBE's proposed trust ecosystem connects digital identity, business verification and professional credentials into portable "Trust Passports" — so verified information can be proven once and shared, with consent, across organisations. Healthcare is one natural application, but the ambition spans multiple sectors and international markets.

Available today
  • Core digital identity verification
  • Early business verification tools
  • Foundational credential checks
In development
  • Trust Passports for individuals and organisations
  • Consent-based credential sharing
  • Cross-organisation verification links
Future ambition
  • A connected trust layer across sectors
  • International market expansion
  • An interoperable standard for proof

We label these tiers deliberately. "Available today" is live. "In development" and "Future ambition" describe planned direction, not delivered products — a trust-infrastructure business should never blur the two.

Today — fragmented

Proven, then proven again — everywhere.

  • Every hospital, locum agency and insurer runs its own credential check, from the beginning.
  • Your identity is re-proven from scratch at each new organisation you join.
  • Records sit scattered across disconnected systems that don't talk to each other.
  • Duplicated effort, slow onboarding, and verification that expires the moment you move on.

The proposed model — connected

Proven once, shared with consent.

  • Verified identity, credentials and ownership are established a single time.
  • A Trust Passport travels with you, re-usable across organisations.
  • Information is shared only with your explicit consent, organisation to organisation.
  • Onboarding becomes a confirmation, not a re-investigation.

Why This May Interest You

You Already Understand the Problem. Now Explore the Business Building a Solution.

You know, better than most, that credibility is earned through evidence — and you feel the cost of duplicated checks and disconnected systems every time you take on a new post, a new hospital, a new agency. That lived understanding gives you a genuinely useful lens for evaluating a trust-infrastructure business.

Understanding the problem intimately is a real advantage when assessing whether a company's proposed solution makes sense. That is exactly why this invitation is extended to medical professionals.

An honest distinction

Owning iQUBE shares is a financial investment, entirely separate from using the technology. Share ownership does not guarantee patients, referrals, professional advantages or any clinical benefit of any kind.

A Private Investment Opportunity. Starting From US$1,000.

Clear, specific figures — so you can see exactly what is being proposed before you decide to look deeper.

US$1,000

Proposed minimum investment

US$2

Proposed private price per share

US$10

Management's targeted future listing price per share, not guaranteed

At US$2 per share, US$1,000 would buy 500 shares, before fees or adjustments.

Please read before proceeding

No Nasdaq listing, future valuation, liquidity or investor return is guaranteed. The US$10 figure is a management target — not a confirmed IPO price, a guaranteed return, or an assured exit.

Final price, structure, dilution, restrictions and timing may differ, and the company might not list at all. The proposed exchange is noted factually as Nasdaq for reference only; this is not an endorsement or confirmation.

The investor pack is the proper source for share class, rights, valuation, dilution, the funding plan and the full risks. Please review it before forming any view.

The company's next chapter

Be Part of the Company's Next Chapter.

iQUBE is pursuing a proposed US listing pathway and is seeking to broaden its shareholder base ahead of that journey. This is framed as a chance to learn about a developing global technology business before any potential listing — not a promise that one will occur.

Management has spoken of a 300-investor recruitment objective. It's important to be precise about what that means.

Qualifying for Nasdaq requires considerably more than a target number of investors — applicable shareholder distribution, unrestricted shareholding and other admission conditions must be met. Eligibility and qualifying shareholdings are assessed separately, and buying restricted private shares does not, by itself, satisfy Nasdaq's round-lot or distribution criteria. There are no deadlines and no scarcity attached to this invitation.

Your Next Step

You're Busy Looking After Everyone Else. Take Two Minutes to Explore Something for Yourself.

1

Request the information

Complete the short form below. This does not constitute an investment application, allocation or purchase of any kind.

2

Review the investor pack

Read the company's pack at your own pace — share class, rights, valuation, dilution, funding plan and the full risks.

3

Arrange a conversation

If, and only if, it interests you, arrange a personal conversation. No pressure, no obligation.

What happens after you register

Completing this form registers your interest only. It is not an investment application, an allocation, or a purchase, and it commits you to nothing.

We will send the company information so you can review your eligibility for this private opportunity. Your details are handled under our privacy notice and never sold. You can withdraw consent at any time.

"Thank you for registering your interest. The next step is to receive the company information and review your eligibility for this private opportunity."

Your Private Invitation Starts Here.

Two minutes. No obligation. Yours to review.

By registering you request information only. This is not an investment application, allocation or purchase.

Capital at risk. Private, illiquid, pre-IPO shares. No listing, return or exit is guaranteed.

In Plain Language

Questions, Answered Simply.

What is the minimum I can invest?

The proposed minimum investment is US$1,000. At the proposed private price of US$2 per share, that would buy 500 shares, before any fees or adjustments. Figures are proposals set out in the investor pack, not a final offer.

What does iQUBE actually do?

iQUBE is building proposed trust infrastructure — digital identity, business verification and credential tools that aim to connect into portable "Trust Passports", so verified information can be proven once and shared with consent across organisations. Some elements are live today; others are in development or future ambition.

Does registering commit me to anything?

No. Completing the form registers your interest and requests the information only. It is not an investment application, an allocation or a purchase, and it obliges you to nothing.

Is iQUBE already listed on a stock exchange?

No. iQUBE is not publicly listed. A listing is proposed and being pursued — it is not confirmed, scheduled or guaranteed, and it may not happen.

What are the risks?

These are private, illiquid, pre-IPO shares. Your capital is at risk and you could lose some or all of it. There is no public market, so selling may be difficult or impossible. No return, dividend or exit is guaranteed. Please read the full risk section in the investor pack.

Who is eligible to invest?

Eligibility depends on your country of residence and applicable rules, and is assessed separately on a case-by-case basis. The investor pack and a personal conversation will clarify whether you qualify.

What if the planned listing is delayed or never happens?

That is a genuine possibility you should plan for. A listing is proposed, not certain. If it is delayed or does not occur, the shares may remain private and illiquid indefinitely, with no guaranteed route to sell or realise value. You should only consider this if you are comfortable with that outcome.

Is the US$10 figure a guaranteed price?

No. US$10 is management's targeted future listing price per share — a target, not a confirmed IPO price, a guaranteed return or an assured exit. The actual price, if any listing occurs, may be higher, lower, or never set.